Reuters
Published May 17, 2021 10:23AM ET
Updated May 17, 2021 11:13AM ET
By Emma Farge and Michael Shields
GENEVA (Reuters) -The head of the World Health Organization called on COVID-19 vaccine manufacturers to make shots available to the COVAX vaccine-sharing facility earlier than planned due to a supply shortfall left by Indian export disruptions.
COVAX, which supplies doses to poorer countries, relies heavily on India's Serum Institute's exports of the AstraZeneca (NASDAQ:AZN) shot but many of these are instead being used by the country as it battles a massive second wave of infections.
The head of UNICEF on Monday asked wealthy G7 countries ahead of a summit next month to donate supplies as an emergency measure to make up the shortfall estimated at 140 million doses by end-May.
"While we appreciate the work of AstraZeneca who have been steadily increasing the speed and volume of their deliveries, we need other manufacturers to follow suit," WHO Director-General Tedros Adhanom Ghebreyesus told a virtual briefing.
Specifically, he asked Pfizer (NYSE:PFE) to bring forward deliveries of some 40 million doses in the second half of the year and asked Moderna (NASDAQ:MRNA) to make doses pledged for 2022 available this year.
"We need doses right now and call on them to bring forward deliveries as soon as possible," he said.
G7 member France has already given some AstraZeneca shots to COVAX and talks with Washington on donations are ongoing.
WHO senior adviser Bruce Aylward defended COVAX's work so far in providing 65 million doses to 120 countries, calling it a success. But wealthy countries need to donate more vaccines now they have vaccinated their most vulnerable populations, he said.
"We are moving in the right direction. We are not moving there fast enough and we are not moving there at large enough volumes," he said.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.